Figure 6
Figure 6. Forced expression of Gfi1 partially restores the function of Mysm1-deficient HSC. (A-F) 1 × 103 LSKFlt3− cells sorted from WT or Mysm1−/− mice (CD45.2) and Mysm1−/− LSKFlt3− cells transduced with pMIG-Gfi1 were transplanted into lethally irradiated recipients (CD45.1) together with 2 × 105 competitor BM cells (CD45.1). (A) Flow cytometric analyses of WT, Mysm1−/− CD45.2 cells, and donor-derived chimerism (CD45.2) 6 weeks after transplantation in the recipient mice transplanted with WT, Mysm1−/− cells, and Mysm1−/− cells expressed with Gfi1 (pMIG-Gfi1 Mysm1−/−). (B) Percentages of donor-derived cells (CD45.2) in BM. Each dot indicates an individual recipient mouse. (C-D) Flow cytometric analyses and percentages of donor-derived LSKFlt3+ cells in the recipient mice 6 weeks after transplantation. Each dot indicates an individual recipient mouse. (E-F) Flow cytometric analyses and percentages of donor-derived CD45.2 or CD45.1 cells gated on B220+ B cells, CD3+ T cells, and CD11b+Gr1+ myeloid cells in the recipient mice 6 weeks after transplantation. Each dot indicates an individual recipient mouse. (A-F) Data are representative of two independent experiments with n = 5 mice per group in the first experiment and n = 3 mice per group in the second experiment. Shown are means ± SD of 1st experiment with n = 5 mice per group, ***P < .001. (G-J) Sorted Mysm1−/− LSK cells were infected with retroviral vectors encoding either Gfi1 and GFP (pCDH-Gfi1-GFP) or GFP alone (pCDH-GFP) in vitro. Hoechst 33258/Pyronin Y staining (G), annexin V staining (H), BrdU incorporation assay (I) or cell-cycle analysis (J) were performed 48 hours after infection to monitor G0 phase, apoptosis, proliferation, and cell-cycle profile, respectively. (G-J) Data are representative of three independent experiments, *P < .05.

Forced expression of Gfi1 partially restores the function of Mysm1-deficient HSC. (A-F) 1 × 103 LSKFlt3 cells sorted from WT or Mysm1−/− mice (CD45.2) and Mysm1−/− LSKFlt3 cells transduced with pMIG-Gfi1 were transplanted into lethally irradiated recipients (CD45.1) together with 2 × 105 competitor BM cells (CD45.1). (A) Flow cytometric analyses of WT, Mysm1−/− CD45.2 cells, and donor-derived chimerism (CD45.2) 6 weeks after transplantation in the recipient mice transplanted with WT, Mysm1−/− cells, and Mysm1−/− cells expressed with Gfi1 (pMIG-Gfi1 Mysm1−/−). (B) Percentages of donor-derived cells (CD45.2) in BM. Each dot indicates an individual recipient mouse. (C-D) Flow cytometric analyses and percentages of donor-derived LSKFlt3+ cells in the recipient mice 6 weeks after transplantation. Each dot indicates an individual recipient mouse. (E-F) Flow cytometric analyses and percentages of donor-derived CD45.2 or CD45.1 cells gated on B220+ B cells, CD3+ T cells, and CD11b+Gr1+ myeloid cells in the recipient mice 6 weeks after transplantation. Each dot indicates an individual recipient mouse. (A-F) Data are representative of two independent experiments with n = 5 mice per group in the first experiment and n = 3 mice per group in the second experiment. Shown are means ± SD of 1st experiment with n = 5 mice per group, ***P < .001. (G-J) Sorted Mysm1−/− LSK cells were infected with retroviral vectors encoding either Gfi1 and GFP (pCDH-Gfi1-GFP) or GFP alone (pCDH-GFP) in vitro. Hoechst 33258/Pyronin Y staining (G), annexin V staining (H), BrdU incorporation assay (I) or cell-cycle analysis (J) were performed 48 hours after infection to monitor G0 phase, apoptosis, proliferation, and cell-cycle profile, respectively. (G-J) Data are representative of three independent experiments, *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal